CollPlant Biotechnologies Ltd Reimbursement Rights At Fair Value
CollPlant Biotechnologies Ltd (CLGN) had Reimbursement Rights At Fair Value of $1.00 million as of 2019-12-31, per its 20-F filed 2020-04-01.
Discontinued › Notes
ifrs-full:ReimbursementRightsAtFairValue · last filed 2020-04-01
- 2019-12-31: Reimbursement Rights At Fair Value $1.00M.
| Period end | Reimbursement Rights At Fair Value |
|---|---|
| 2019-12-31 | $1.00M 20-F · filed 2020-04-01 |